Articles From: AES Reveals Battery Integration Center, LG Chem and Parker Hannifin are Initial Partners to Aeterna Zentaris Reports Fourth Quarter and Full-Year 2013 Financial and Operating Results


2014/3/6
AES Energy Storage today revealed the AES Battery Integration Center, a technology center located in Indianapolis, Ind., that evaluates advanced battery and power conversion technologies for use in AES Advancion™ – a complete battery-based energy storage offering, which is now available to utility buyers and renewable developers in select markets.
Sign-up for AES Reveals Battery Integration Center, LG Chem and Parker Hannifin are Initial Partners investment picks
2014/1/23
AES Energy Storage, a subsidiary of The AES Corporation (NYSE:AES), today announced that its fleet of advanced grid storage solutions achieved an important milestone by surpassing 1.5 million MW-h of delivered service in the U.S. and Chile.
Sign-up for AES Storage Solutions Surpass 1.5 Million Megawatt-Hours of Delivered Service investment picks
2013/11/7
The AES Corporation (NYSE:AES) announced that it has signed agreements to sell its electric generation and distribution businesses in Cameroon to Actis, a global pan-emerging market investor, for $220 million of net equity proceeds.
Sign-up for AES to Sell Cameroon Businesses; Provides Update on Asset Sales investment picks
Aeterna Zentaris Announces Closing of US$13.2 Million Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Announces Closing of US$13.2 Million Public Offering of Common Shares and Warrants investment picks
2014/1/14
QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Announces Closing of US$13.2 Million Public Offering of Common Shares and Warrants investment picks
Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Closing of US$15.1 Million Public Offering of Common Shares and Warrants investment picks
2014/3/28
Aeterna Zentaris Announces Effectiveness of $50 Million Shelf Registration Statement for "At-the-Market" Common Share Issuance Programs Canada NewsWire All amounts are in US dollars QUÉBEC CITY, March 28, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its shelf registration statement on Form F-3 previously filed with the Securities and Exchange Commission (the "SEC") has been declared effective by the SEC.
Sign-up for Aeterna Zentaris Announces Effectiveness of $50 Million Shelf Registration Statement for "At-the-Market" Common Share Issuance Programs investment picks
2014/3/28
All amounts are in US dollars QUÉBEC CITY, March 28, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that its shelf registration statement on Form F-3 previously filed with the Securities and Exchange Commission (the "SEC") has been declared effective by the SEC.
Sign-up for Aeterna Zentaris Announces Effectiveness of $50 Million Shelf Registration Statement for "At-the-Market" Common Share Issuance Programs investment picks
Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market Canada NewsWire QUÉBEC CITY, Aug.
Sign-up for Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market investment picks
QUÉBEC CITY, Aug.
Sign-up for Aeterna Zentaris Announces Listing Transfer to NASDAQ Capital Market investment picks
2014/1/9
QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Announces Pricing of US$13.2 Million Public Offering of Common Shares and Warrants investment picks
2014/1/9
Aeterna Zentaris Announces Pricing of US$13.2 Million Public Offering of Common Shares and Warrants Canada NewsWire Canaccord Genuity Inc. is acting as the sole book-running manager for the Offering.
Sign-up for Aeterna Zentaris Announces Pricing of US$13.2 Million Public Offering of Common Shares and Warrants investment picks
2013/11/20
Aeterna Zentaris Announces Pricing of US$15.1 Million Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Pricing of US$15.1 Million Public Offering of Common Shares and Warrants investment picks
2013/11/20
QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Pricing of US$15.1 Million Public Offering of Common Shares and Warrants investment picks
QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants investment picks
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants Canada NewsWire QUÉBEC CITY, QC, Jan.
Sign-up for Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants investment picks
2014/1/8
QUÉBEC CITY, QC, Jan.
Sign-up for Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants investment picks
All amounts are in US dollars QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision investment picks
Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision Canada NewsWire All amounts are in US dollars QUÉBEC CITY, Nov.
Sign-up for Aeterna Zentaris Appoints Chief Commercial Officer, Reaffirming New Company Vision investment picks
QUÉBEC CITY, Jan.
Sign-up for Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer investment picks
Aeterna Zentaris Appoints Dr.
Sign-up for Aeterna Zentaris Appoints Dr. Richard Sachse as Chief Scientific Officer investment picks
2013/7/30
(All amounts are in US dollars) QUEBEC CITY , July 30, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") announced today that it has completed its previously announced registered direct offering of $7.8 million of units comprised of common shares and common share purchase warrants to certain institutional investors.
Sign-up for Aeterna Zentaris Completes $7.8 Million Registered Direct Offering investment picks
2013/10/1
Company to Receive $3.3 Million One-Time Payment All amounts are in US dollars (unless otherwise mentioned) QUÉBEC CITY, Oct.
Sign-up for Aeterna Zentaris Completes Successful Transfer of Cetrotide® Manufacturing Rights to Merck KGaA investment picks
Aeterna Zentaris Completes Successful Transfer of Cetrotide® Manufacturing Rights to Merck KGaA Canada NewsWire Company to Receive $3.3 Million One-Time Payment All amounts are in US dollars (unless otherwise mentioned) QUÉBEC CITY, Oct.
Sign-up for Aeterna Zentaris Completes Successful Transfer of Cetrotide® Manufacturing Rights to Merck KGaA investment picks
QUEBEC CITY , Jan.
Sign-up for Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA investment picks
Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA Canada NewsWire QUEBEC CITY , Jan.
Sign-up for Aeterna Zentaris NDA for Macimorelin Acetate in AGHD Accepted for Filing by the FDA investment picks
2014/3/20
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2013 Financial and Operating Results Canada NewsWire All amounts are in US dollars QUEBEC CITY , March 20, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2013 .
Sign-up for Aeterna Zentaris Reports Fourth Quarter and Full-Year 2013 Financial and Operating Results investment picks
2014/3/20
All amounts are in US dollars QUEBEC CITY, March 20, 2014 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company"), a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2013 .
Sign-up for Aeterna Zentaris Reports Fourth Quarter and Full-Year 2013 Financial and Operating Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AES Reveals Battery Integration Center, LG Chem and Parker Hannifin are Initial Partners to Aeterna Zentaris Reports Fourth Quarter and Full-Year 2013 Financial and Operating Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity